Recent content from Jim Spencer
Leaders in Minnesota's health care community called the Senate Republican health care reform bill disappointing because of the GOP's continued insistence on significantly cutting Medicaid.
Executives predict big losses from Trump's budget or the Republicans' AHCA.
President Trump's vow to renegotiate the trade pact with Canada and Mexico could have big impact on Minnesota's economy.
Elizabeth Kautz, a Republican and former mayor's conference president, broke sharply from her Republican colleagues in Washington.
Among them are some of the biggest names in the state: Cargill, 3M, Target, Best Buy and General Mills.
The endorsement bolsters activist investor Marcato Capital Management's bid to shake up the company.
Proponents of the border adjustment told Congress it would aid U.S. manufacturing.
Proposed rule could drive price increases for retailers.
A fierce debate is underway in Washington over whether to restructure the Consumer Finance Protection Bureau or perhaps eliminate it.
Growth rates throughout the Upper Midwest lagged most other regions of the country, according to the U.S. Bureau of Economic Analysis.
The U.S. Department of Labor is investigating certain investments, expenses, loans and distributions made by 3M's pension plan, the company revealed this week in a Securities and Exchange Commission filing.
Groups representing health-care consumers are decidedly against the legislation, which could mean changes for employers plans, too.
Current process is too "erratic," Medtronic exec tells Congress.
The omission of a so-called "border adjustment" tax is good news for Target, Best Buy, Polaris and others.
Companies big and small are looking to carve out a chunk of the hot sector.
Mayo Clinic, U and Medtronic among top employers in state for visa fillings.
Compass Airlines, a contract carrier which flies for Delta as Delta Connection, will move its flight operations to the West Coast from Minneapolis-St. Paul International Airport, taking more than 100 Twin Cities-based jobs with it.
AdvaMed wants to end Obamacare's 2.5% levy.
Al Franken and Amy Klobuchar hope the timing is right for a major consumer bill.
Member views often diverge in the heat of a lobbying battle.
While the arcane precedent recognizing the right of civil servants to write policies that implement U.S. laws may sound boring, sacking it, as Gorsuch has suggested, will resonate for businesses and citizens across the country.
Minnesotans who are older and less affluent would get significantly fewer tax credits from the new Republican national health care plan, according to a new analysis.
WASHINGTON – Last week, the U.S. Senate killed a rule that in part required federal contractors to report and correct safety violations in order…
At the U.S. Senate, the former Fox News anchor talks of sexual harassment case and the inability to go to trial.
The state's device makers stand to gain if Supreme Court nominee confirmed.
FICTION: Saga follows several flawed characters through a Wisconsin Boy Scout camp, war and adulthood.
President Trump called the meeting 'a great listening session,' and said a tax proposal would be coming soon.
The retail industry argues that a border adjustment tax would be costly for consumers.
Richard Painter has yet to become the subject of a Donald Trump tweet. That’s fine with the University of Minnesota law professor. On the other…
Mexican import tax could severely harm agriculture sector.
WASHINGTON – Minnesota-based Cargill, Land O’Lakes and CHS Inc. have joined more than 100 agriculture-related companies and trade associations to sing the praises of…
Deals with Minnesota's top foreign partners upended.
Millions rally in historic protests against Trump.
Minn. Republicans in DC strike upbeat note, but Democrats hear little to like from Trump
Lawsuit cites $35 service fee to cover each overdraft. The bank said it has treated customers fairly and will defend itself against the allegations.
Trump administration has made its opposition clear.
With GOP in control, his chances look excellent.
Charlie Weaver got a sense of the new world order when he found himself begging Republicans in the U.S. Senate and House to vote for the Trans-Pacific Partnership.
The suit follows a $11.5 million fraud settlement that the state reached with the automaker.
The judge's ruling could make sealed records public, where they would be available for additional cases.
Senators were skeptical of the claim by the CEOS of the two companies that their megadeal would result in lower prices.
The bill makes changes in regulatory review and helps to finance research.
Howard Root said he would rather step away from the Maple Grove-based business he co-founded and ran for 20 years than face the risks that he says come from running a publicly traded medical device company.
WASHINGTON — The 21st Century Cures Act, which speeds up approval of medical devices and drugs and sets up a sweeping medical research framework for…
Included in the bill, which heads to the Senate, are key changes in the regulatory process used to evaluate new medical devices.
Minnesota businesses whose growth plans depend on exports will face a new obstacle if President-elect Trump enacts the trade program he outlined during the campaign.
FICTION: A wise but gimmicky novel about a film producer who uses time travel and visiting ghosts to look back on how the world has changed for women.
The ruling gives the company until February to work out plan to restart its stalled Nashwauk project.
The FDA is grappling with how far companies can go in touting uses that haven't been studied.
They want freer exchanges on unapproved uses; critics are leery.
It "stands in the way" of keeping public informed.
A former sales rep alleges the company misrepresented how the device would be used.
They wonder if product was intentionally misclassified to lower rebates paid to Medicaid.
Within hours of AT&T's announcement that it had agreed to buy Time Warner for $85.4 billion, U.S. Sen. Al Franken of Minnesota put out a statement saying he was "skeptical of huge media mergers."
WASHINGTON – The Senate Judiciary Committee has scheduled a Nov. 30 hearing to discuss pricing policies for the Mylan Pharmaceuticals EpiPen epinephrine injector that…
Patient safety advocates welcome move, but say enforcement is the key.
Debate over forced arbitration finds its second wind, with help from events like Wells Fargo scandal
WASHINGTON – Nearly eight years after launching a legislative assault on binding arbitration clauses buried in service and employment contracts, U.S. Sen. Al Franken,…
It "stands in the way" of keeping public informed.
"Physicians might change their minds if they knew how many problems there really were," said a former FDA official who left the agency to found a search engine that tracks device performance.
WASHINGTON – Federal Medicare and Medicaid payments for Mylan Pharmaceutical’s EpiPen epinephrine injector rose from roughly $86 million in 2011 to about $487 million…
FICTION: In lawyer turned writer Allen Eskens' third mystery, troubled detective Max Rupert investigates and broods.
The fiscal committee, led by Minnesotans, says it is off the voters' minds, too.
While income growth remains a worry, fewer people are living in poverty and the ranks of the uninsured have thinned.
In a letter to U.S. Attorney General Loretta Lynch, they question how Mylan classified device in order to lower rebates.
Hybrid approach would allow benefits to change if needed, but critics say the approach poses risks for workers.
Stumpf apologized, but wouldn't call what happened 'fraud'
The trove of personal data that Pokemon Go and other popular smartphone apps obtain and keep on users has led privacy advocates to warn that players risk having personal details exploited commercially and possibly criminally.
Schools and manufacturers find they must team up to nurture a talent pool.
Opponents include labor unions that say the changes provide inadequate protections for workers.
Device's "non-innovator" status is estimated to be costing states millions in Medicaid overpayments.
Auto-injector was inappropriately given generic designation, she says.
A letter from senators sent Tuesday questions Mylan's plans to introduce half-price generic.
Mylan CEO says pricing is only "part of the problem."
Amy Klobuchar is among several senators criticizing sharp price rise for product she calls a 'life preserver' for millions.
New protectionist stance tests traditional alliance.
More from Star Tribune